Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents.
D000367:Age Factors; D000818:Animals; D000931:Antidotes / Q000138:chemical synthesis*; D055598:Chemical Phenomena; D002621:Chemistry; D002800:Cholinesterase Inhibitors / Q000633:toxicity*; D002801:Cholinesterase Reactivators / Q000138:chemical synthesis*; D006801:Humans; D007531:Isoflurophate / Q000633:toxicity; D007700:Kinetics; D007928:Lethal Dose 50; D009943:Organophosphorus Compounds / Q000633:toxicity*; D011726:Pyridinium Compounds / Q000138:chemical synthesis; D013329:Structure-Activity Relationship
D000931:Antidotes; D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D009943:Organophosphorus Compounds; D011726:Pyridinium Compounds; D007531:Isoflurophate